Global Polio Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.
Polio Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Polio Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.
Polio Vaccine segment by Company
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Polio Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Polio Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Polio Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Polio Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Polio Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL POLIO VACCINE MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 POLIO VACCINE MARKET BY MANUFACTURERS
3.1 Global Polio Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Polio Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Polio Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Polio Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Polio Vaccine Manufacturers, Product Type & Application
3.7 Global Polio Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Polio Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier
4 POLIO VACCINE MARKET BY TYPE
4.1 Polio Vaccine Type Introduction
4.1.1 Inactivated Polio Vaccine (IPV)
4.1.2 Oral Polio Vaccine (OPV)
4.2 Global Polio Vaccine Sales by Type
4.2.1 Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Polio Vaccine Sales by Type (2019-2030)
4.2.3 Global Polio Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Polio Vaccine Revenue by Type
4.3.1 Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Polio Vaccine Revenue by Type (2019-2030)
4.3.3 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
5 POLIO VACCINE MARKET BY APPLICATION
5.1 Polio Vaccine Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Polio Vaccine Sales by Application
5.2.1 Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales by Application (2019-2030)
5.2.3 Global Polio Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Polio Vaccine Revenue by Application
5.3.1 Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Polio Vaccine Revenue by Application (2019-2030)
5.3.3 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL POLIO VACCINE SALES BY REGION
6.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Polio Vaccine Sales by Region (2019-2030)
6.2.1 Global Polio Vaccine Sales by Region (2019-2024)
6.2.2 Global Polio Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Polio Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Polio Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Polio Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Polio Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL POLIO VACCINE REVENUE BY REGION
7.1 Global Polio Vaccine Revenue by Region
7.1.1 Global Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Polio Vaccine Revenue by Region (2019-2024)
7.1.3 Global Polio Vaccine Revenue by Region (2025-2030)
7.1.4 Global Polio Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Polio Vaccine Revenue (2019-2030)
7.2.2 North America Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Polio Vaccine Revenue (2019-2030)
7.3.2 Europe Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Polio Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Polio Vaccine Revenue (2019-2030)
7.5.2 LAMEA Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Sanofi Polio Vaccine Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Polio Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Bibcol
8.3.1 Bibcol Comapny Information
8.3.2 Bibcol Business Overview
8.3.3 Bibcol Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Bibcol Polio Vaccine Product Portfolio
8.3.5 Bibcol Recent Developments
8.4 Serum Institute
8.4.1 Serum Institute Comapny Information
8.4.2 Serum Institute Business Overview
8.4.3 Serum Institute Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Serum Institute Polio Vaccine Product Portfolio
8.4.5 Serum Institute Recent Developments
8.5 Tiantan Biological
8.5.1 Tiantan Biological Comapny Information
8.5.2 Tiantan Biological Business Overview
8.5.3 Tiantan Biological Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Tiantan Biological Polio Vaccine Product Portfolio
8.5.5 Tiantan Biological Recent Developments
8.6 IMBCA
8.6.1 IMBCA Comapny Information
8.6.2 IMBCA Business Overview
8.6.3 IMBCA Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 IMBCA Polio Vaccine Product Portfolio
8.6.5 IMBCA Recent Developments
8.7 Panacea Biotec Ltd
8.7.1 Panacea Biotec Ltd Comapny Information
8.7.2 Panacea Biotec Ltd Business Overview
8.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
8.7.5 Panacea Biotec Ltd Recent Developments
8.8 Bio-Med
8.8.1 Bio-Med Comapny Information
8.8.2 Bio-Med Business Overview
8.8.3 Bio-Med Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Bio-Med Polio Vaccine Product Portfolio
8.8.5 Bio-Med Recent Developments
8.9 Halfkin Bio-Pharmaceuticals
8.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.9.2 Halfkin Bio-Pharmaceuticals Business Overview
8.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
8.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Polio Vaccine Value Chain Analysis
9.1.1 Polio Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Polio Vaccine Production Mode & Process
9.2 Polio Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Polio Vaccine Distributors
9.2.3 Polio Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Polio Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Polio Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Polio Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Polio Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL POLIO VACCINE MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 POLIO VACCINE MARKET BY MANUFACTURERS
3.1 Global Polio Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Polio Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Polio Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Polio Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Polio Vaccine Manufacturers, Product Type & Application
3.7 Global Polio Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Polio Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Polio Vaccine Tier 1, Tier 2, and Tier
4 POLIO VACCINE MARKET BY TYPE
4.1 Polio Vaccine Type Introduction
4.1.1 Inactivated Polio Vaccine (IPV)
4.1.2 Oral Polio Vaccine (OPV)
4.2 Global Polio Vaccine Sales by Type
4.2.1 Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Polio Vaccine Sales by Type (2019-2030)
4.2.3 Global Polio Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Polio Vaccine Revenue by Type
4.3.1 Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Polio Vaccine Revenue by Type (2019-2030)
4.3.3 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
5 POLIO VACCINE MARKET BY APPLICATION
5.1 Polio Vaccine Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Polio Vaccine Sales by Application
5.2.1 Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales by Application (2019-2030)
5.2.3 Global Polio Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Polio Vaccine Revenue by Application
5.3.1 Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Polio Vaccine Revenue by Application (2019-2030)
5.3.3 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL POLIO VACCINE SALES BY REGION
6.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Polio Vaccine Sales by Region (2019-2030)
6.2.1 Global Polio Vaccine Sales by Region (2019-2024)
6.2.2 Global Polio Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Polio Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Polio Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Polio Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Polio Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL POLIO VACCINE REVENUE BY REGION
7.1 Global Polio Vaccine Revenue by Region
7.1.1 Global Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Polio Vaccine Revenue by Region (2019-2024)
7.1.3 Global Polio Vaccine Revenue by Region (2025-2030)
7.1.4 Global Polio Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Polio Vaccine Revenue (2019-2030)
7.2.2 North America Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Polio Vaccine Revenue (2019-2030)
7.3.2 Europe Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Polio Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Polio Vaccine Revenue (2019-2030)
7.5.2 LAMEA Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Sanofi Polio Vaccine Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Polio Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 Bibcol
8.3.1 Bibcol Comapny Information
8.3.2 Bibcol Business Overview
8.3.3 Bibcol Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Bibcol Polio Vaccine Product Portfolio
8.3.5 Bibcol Recent Developments
8.4 Serum Institute
8.4.1 Serum Institute Comapny Information
8.4.2 Serum Institute Business Overview
8.4.3 Serum Institute Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Serum Institute Polio Vaccine Product Portfolio
8.4.5 Serum Institute Recent Developments
8.5 Tiantan Biological
8.5.1 Tiantan Biological Comapny Information
8.5.2 Tiantan Biological Business Overview
8.5.3 Tiantan Biological Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Tiantan Biological Polio Vaccine Product Portfolio
8.5.5 Tiantan Biological Recent Developments
8.6 IMBCA
8.6.1 IMBCA Comapny Information
8.6.2 IMBCA Business Overview
8.6.3 IMBCA Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 IMBCA Polio Vaccine Product Portfolio
8.6.5 IMBCA Recent Developments
8.7 Panacea Biotec Ltd
8.7.1 Panacea Biotec Ltd Comapny Information
8.7.2 Panacea Biotec Ltd Business Overview
8.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
8.7.5 Panacea Biotec Ltd Recent Developments
8.8 Bio-Med
8.8.1 Bio-Med Comapny Information
8.8.2 Bio-Med Business Overview
8.8.3 Bio-Med Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Bio-Med Polio Vaccine Product Portfolio
8.8.5 Bio-Med Recent Developments
8.9 Halfkin Bio-Pharmaceuticals
8.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.9.2 Halfkin Bio-Pharmaceuticals Business Overview
8.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
8.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Polio Vaccine Value Chain Analysis
9.1.1 Polio Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Polio Vaccine Production Mode & Process
9.2 Polio Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Polio Vaccine Distributors
9.2.3 Polio Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Polio Vaccine Industry Trends
Table 2. Polio Vaccine Industry Drivers
Table 3. Polio Vaccine Industry Opportunities and Challenges
Table 4. Polio Vaccine Industry Restraints
Table 5. Global Polio Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Polio Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Polio Vaccine Sales Market Share by Manufacturers
Table 9. Global Polio Vaccine Average Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 10. Global Polio Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Polio Vaccine Manufacturers, Product Type & Application
Table 13. Global Polio Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Polio Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 17. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 18. Global Polio Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 19. Global Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Global Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 21. Global Polio Vaccine Sales Market Share by Type (2019-2024)
Table 22. Global Polio Vaccine Sales Market Share by Type (2025-2030)
Table 23. Global Polio Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 24. Global Polio Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 25. Global Polio Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 26. Global Polio Vaccine Revenue Market Share by Type (2019-2024)
Table 27. Global Polio Vaccine Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Public
Table 29. Major Manufacturers of Private
Table 30. Global Polio Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 31. Global Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 32. Global Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 33. Global Polio Vaccine Sales Market Share by Application (2019-2024)
Table 34. Global Polio Vaccine Sales Market Share by Application (2025-2030)
Table 35. Global Polio Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Polio Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 37. Global Polio Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 38. Global Polio Vaccine Revenue Market Share by Application (2019-2024)
Table 39. Global Polio Vaccine Revenue Market Share by Application (2025-2030)
Table 40. Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 41. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 42. Global Polio Vaccine Sales Market Share by Region (2019-2024)
Table 43. Global Polio Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 44. Global Polio Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 45. North America Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 46. North America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. North America Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 48. Europe Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 49. Europe Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 50. Europe Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 51. Asia Pacific Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 52. Asia Pacific Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 53. Asia Pacific Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 54. LAMEA Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. LAMEA Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. LAMEA Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 57. Global Polio Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. Global Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 59. Global Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 60. Global Polio Vaccine Revenue Market Share by Region (2019-2024)
Table 61. Global Polio Vaccine Revenue Market Share by Region (2025-2030)
Table 62. Sanofi Company Information
Table 63. Sanofi Business Overview
Table 64. Sanofi Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Sanofi Polio Vaccine Product Portfolio
Table 66. Sanofi Recent Development
Table 67. GSK Company Information
Table 68. GSK Business Overview
Table 69. GSK Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. GSK Polio Vaccine Product Portfolio
Table 71. GSK Recent Development
Table 72. Bibcol Company Information
Table 73. Bibcol Business Overview
Table 74. Bibcol Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. Bibcol Polio Vaccine Product Portfolio
Table 76. Bibcol Recent Development
Table 77. Serum Institute Company Information
Table 78. Serum Institute Business Overview
Table 79. Serum Institute Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. Serum Institute Polio Vaccine Product Portfolio
Table 81. Serum Institute Recent Development
Table 82. Tiantan Biological Company Information
Table 83. Tiantan Biological Business Overview
Table 84. Tiantan Biological Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Tiantan Biological Polio Vaccine Product Portfolio
Table 86. Tiantan Biological Recent Development
Table 87. IMBCA Company Information
Table 88. IMBCA Business Overview
Table 89. IMBCA Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. IMBCA Polio Vaccine Product Portfolio
Table 91. IMBCA Recent Development
Table 92. Panacea Biotec Ltd Company Information
Table 93. Panacea Biotec Ltd Business Overview
Table 94. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 95. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 96. Panacea Biotec Ltd Recent Development
Table 97. Bio-Med Company Information
Table 98. Bio-Med Business Overview
Table 99. Bio-Med Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 100. Bio-Med Polio Vaccine Product Portfolio
Table 101. Bio-Med Recent Development
Table 102. Halfkin Bio-Pharmaceuticals Company Information
Table 103. Halfkin Bio-Pharmaceuticals Business Overview
Table 104. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 105. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 106. Halfkin Bio-Pharmaceuticals Recent Development
Table 107. Key Raw Materials
Table 108. Raw Materials Key Suppliers
Table 109. Polio Vaccine Distributors List
Table 110. Polio Vaccine Customers List
Table 111. Research Programs/Design for This Report
Table 112. Authors List of This Report
Table 113. Secondary Sources
Table 114. Primary Sources
Table 1. Polio Vaccine Industry Trends
Table 2. Polio Vaccine Industry Drivers
Table 3. Polio Vaccine Industry Opportunities and Challenges
Table 4. Polio Vaccine Industry Restraints
Table 5. Global Polio Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Polio Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Polio Vaccine Sales Market Share by Manufacturers
Table 9. Global Polio Vaccine Average Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 10. Global Polio Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Polio Vaccine Manufacturers, Product Type & Application
Table 13. Global Polio Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Polio Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 17. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 18. Global Polio Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 19. Global Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 20. Global Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 21. Global Polio Vaccine Sales Market Share by Type (2019-2024)
Table 22. Global Polio Vaccine Sales Market Share by Type (2025-2030)
Table 23. Global Polio Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 24. Global Polio Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 25. Global Polio Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 26. Global Polio Vaccine Revenue Market Share by Type (2019-2024)
Table 27. Global Polio Vaccine Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Public
Table 29. Major Manufacturers of Private
Table 30. Global Polio Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 31. Global Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 32. Global Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 33. Global Polio Vaccine Sales Market Share by Application (2019-2024)
Table 34. Global Polio Vaccine Sales Market Share by Application (2025-2030)
Table 35. Global Polio Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 36. Global Polio Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 37. Global Polio Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 38. Global Polio Vaccine Revenue Market Share by Application (2019-2024)
Table 39. Global Polio Vaccine Revenue Market Share by Application (2025-2030)
Table 40. Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 41. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 42. Global Polio Vaccine Sales Market Share by Region (2019-2024)
Table 43. Global Polio Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 44. Global Polio Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 45. North America Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 46. North America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 47. North America Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 48. Europe Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 49. Europe Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 50. Europe Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 51. Asia Pacific Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 52. Asia Pacific Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 53. Asia Pacific Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 54. LAMEA Polio Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. LAMEA Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 56. LAMEA Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 57. Global Polio Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. Global Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 59. Global Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 60. Global Polio Vaccine Revenue Market Share by Region (2019-2024)
Table 61. Global Polio Vaccine Revenue Market Share by Region (2025-2030)
Table 62. Sanofi Company Information
Table 63. Sanofi Business Overview
Table 64. Sanofi Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 65. Sanofi Polio Vaccine Product Portfolio
Table 66. Sanofi Recent Development
Table 67. GSK Company Information
Table 68. GSK Business Overview
Table 69. GSK Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 70. GSK Polio Vaccine Product Portfolio
Table 71. GSK Recent Development
Table 72. Bibcol Company Information
Table 73. Bibcol Business Overview
Table 74. Bibcol Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 75. Bibcol Polio Vaccine Product Portfolio
Table 76. Bibcol Recent Development
Table 77. Serum Institute Company Information
Table 78. Serum Institute Business Overview
Table 79. Serum Institute Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 80. Serum Institute Polio Vaccine Product Portfolio
Table 81. Serum Institute Recent Development
Table 82. Tiantan Biological Company Information
Table 83. Tiantan Biological Business Overview
Table 84. Tiantan Biological Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 85. Tiantan Biological Polio Vaccine Product Portfolio
Table 86. Tiantan Biological Recent Development
Table 87. IMBCA Company Information
Table 88. IMBCA Business Overview
Table 89. IMBCA Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 90. IMBCA Polio Vaccine Product Portfolio
Table 91. IMBCA Recent Development
Table 92. Panacea Biotec Ltd Company Information
Table 93. Panacea Biotec Ltd Business Overview
Table 94. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 95. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 96. Panacea Biotec Ltd Recent Development
Table 97. Bio-Med Company Information
Table 98. Bio-Med Business Overview
Table 99. Bio-Med Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 100. Bio-Med Polio Vaccine Product Portfolio
Table 101. Bio-Med Recent Development
Table 102. Halfkin Bio-Pharmaceuticals Company Information
Table 103. Halfkin Bio-Pharmaceuticals Business Overview
Table 104. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 105. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 106. Halfkin Bio-Pharmaceuticals Recent Development
Table 107. Key Raw Materials
Table 108. Raw Materials Key Suppliers
Table 109. Polio Vaccine Distributors List
Table 110. Polio Vaccine Customers List
Table 111. Research Programs/Design for This Report
Table 112. Authors List of This Report
Table 113. Secondary Sources
Table 114. Primary Sources
LIST OF FIGURES
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Polio Vaccine Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Inactivated Polio Vaccine (IPV) Picture
Figure 9. Oral Polio Vaccine (OPV) Picture
Figure 10. Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 11. Global Polio Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Polio Vaccine Sales Market Share by Type (2019-2030)
Figure 13. Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Polio Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Polio Vaccine Revenue Market Share by Type (2019-2030)
Figure 16. Public Picture
Figure 17. Private Picture
Figure 18. Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 19. Global Polio Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 20. Global Polio Vaccine Sales Market Share by Application (2019-2030)
Figure 21. Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 22. Global Polio Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 23. Global Polio Vaccine Revenue Market Share by Application (2019-2030)
Figure 24. North America Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 25. North America Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 26. U.S. Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 27. Canada Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Europe Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 30. Germany Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. France Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. U.K. Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Italy Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Netherlands Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Asia Pacific Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 37. China Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Japan Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. South Korea Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Southeast Asia Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. India Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Australia Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. LAMEA Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Mexico Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Brazil Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Turkey Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. GCC Countries Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. Global Polio Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Global Polio Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 51. North America Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. North America Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 53. Europe Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Europe Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Asia-Pacific Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 56. Asia-Pacific Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. LAMEA Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 58. LAMEA Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. Polio Vaccine Value Chain
Figure 60. Manufacturing Cost Structure
Figure 61. Polio Vaccine Production Mode & Process
Figure 62. Direct Comparison with Distribution Share
Figure 63. Distributors Profiles
Figure 64. Years Considered
Figure 65. Research Process
Figure 66. Key Executives Interviewed
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Polio Vaccine Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Polio Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Inactivated Polio Vaccine (IPV) Picture
Figure 9. Oral Polio Vaccine (OPV) Picture
Figure 10. Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 11. Global Polio Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Polio Vaccine Sales Market Share by Type (2019-2030)
Figure 13. Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 14. Global Polio Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Polio Vaccine Revenue Market Share by Type (2019-2030)
Figure 16. Public Picture
Figure 17. Private Picture
Figure 18. Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 19. Global Polio Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 20. Global Polio Vaccine Sales Market Share by Application (2019-2030)
Figure 21. Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 22. Global Polio Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 23. Global Polio Vaccine Revenue Market Share by Application (2019-2030)
Figure 24. North America Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 25. North America Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 26. U.S. Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 27. Canada Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 28. Europe Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. Europe Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 30. Germany Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. France Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. U.K. Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Italy Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 34. Netherlands Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. Asia Pacific Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. Asia Pacific Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 37. China Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Japan Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. South Korea Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Southeast Asia Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 41. India Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Australia Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. LAMEA Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. LAMEA Polio Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Mexico Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Brazil Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 47. Turkey Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 48. GCC Countries Polio Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 49. Global Polio Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 50. Global Polio Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 51. North America Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 52. North America Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 53. Europe Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 54. Europe Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Asia-Pacific Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 56. Asia-Pacific Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. LAMEA Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 58. LAMEA Polio Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. Polio Vaccine Value Chain
Figure 60. Manufacturing Cost Structure
Figure 61. Polio Vaccine Production Mode & Process
Figure 62. Direct Comparison with Distribution Share
Figure 63. Distributors Profiles
Figure 64. Years Considered
Figure 65. Research Process
Figure 66. Key Executives Interviewed
